GROS DAVID-ALEXANDRE C (Chief Executive Officer) received a stock award from ELEDON PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/4/2026ACC: 0001193125-26-333136
DirectorOfficer· Chief Executive Officer
Since Sep 2020
+159.66K
Net shares
Net buyer
$658.4K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
354.45K acquired · 194.79K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+354.45K
Price / share
—
Trade value
—
% of position
3938.4%
7/31/2026
9K→363.45K
Common Stock
Direct
Shares
−194.79K
Price / share
$3.38
Trade value
$658.39K
% of position
53.6%
7/31/2026
363.45K→168.66K
Total
Net shares
+159.66K
Net value
-$658.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/31/2026 | A · Award | +354.45K | — | — | 3938.4% | 9K | 363.45K |
| Common Stock Direct | 7/31/2026 | F · Tax Withholding | −194.79K | $3.38 | $658.39K | 53.6% | 363.45K | 168.66K |
| Total | +159.66K | -$658.39K | ||||||
Derivative Transactions0
No derivative transactions reported